GLP-1s: Lilly, Novo Gallop In India, Generic Firms Gear ‘To Finish The Race’

 
• By Anju Ghangurde
  
GLP-1s
Experts discuss huge untapped opportunities for GLP-1s in markets like India (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Scrip